Global and North America Multivalent Vaccines Market Status and Future Forecast 2013-2023

May 2018 | 71 pages | ID: G921E024952EN
99Strategy

Abstracts

SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• GlaxoSmithKline, plc (U.K.)
• Pfizer, Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Sanofi Pasteur SA (France)
• Astellas Pharma Inc. (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions, Inc. (U.S.)
• Johnson & Johnson (U.S.)
• MedImmune, LLC (U.S.)
• Serum Institute of India Pvt. Ltd. (India)
• Bavarian Nordic (Denmark)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Daiichi Sankyo (Japan)
• Protein Sciences Corporation (U.S.)
• Panacea Biotec (India)

Market by Type

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines

Market by Application

• Pediatrics
• Adults

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 GlaxoSmithKline, plc (U.K.)
7.2 Pfizer, Inc. (U.S.)
7.3 Merck & Co., Inc. (U.S.)
7.4 Sanofi Pasteur SA (France)
7.5 Astellas Pharma Inc. (Japan)
7.6 CSL Limited (Australia)
7.7 Emergent BioSolutions, Inc. (U.S.)
7.8 Johnson & Johnson (U.S.)
7.9 MedImmune, LLC (U.S.)
7.10 Serum Institute of India Pvt. Ltd. (India)
7.11 Bavarian Nordic (Denmark)
7.12 Mitsubishi Tanabe Pharma Corporation (Japan)
7.13 Daiichi Sankyo (Japan)
7.14 Protein Sciences Corporation (U.S.)
7.15 Panacea Biotec (India)

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Multivalent Vaccines
Table Application of Multivalent Vaccines
Table Global Multivalent Vaccines Market by Region, 2013-2017 (Million USD)
Table Global Multivalent Vaccines Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Multivalent Vaccines Market by Company, 2013-2017 (Million USD)
Table Global Multivalent Vaccines Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Multivalent Vaccines Market by Type, 2013-2017 (Million USD)
Table Global Multivalent Vaccines Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Multivalent Vaccines Market by Application, 2013-2017 (Million USD)
Table Global Multivalent Vaccines Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Multivalent Vaccines Market by Region, 2013-2017 (Million USD)
Table North America Multivalent Vaccines Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Multivalent Vaccines Market by Company, 2013-2017 (Million USD)
Table North America Multivalent Vaccines Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Multivalent Vaccines Market by Type, 2013-2017 (Million USD)
Table North America Multivalent Vaccines Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Multivalent Vaccines Market by Application, 2013-2017 (Million USD)
Table North America Multivalent Vaccines Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Multivalent Vaccines Market by Type, 2013-2017 (Million USD)
Table United States Multivalent Vaccines Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Multivalent Vaccines Market by Application, 2013-2017 (Million USD)
Table United States Multivalent Vaccines Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Multivalent Vaccines Market by Type, 2013-2017 (Million USD)
Table Canada Multivalent Vaccines Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Multivalent Vaccines Market by Application, 2013-2017 (Million USD)
Table Canada Multivalent Vaccines Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Multivalent Vaccines Market by Type, 2013-2017 (Million USD)
Table Mexico Multivalent Vaccines Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Multivalent Vaccines Market by Application, 2013-2017 (Million USD)
Table Mexico Multivalent Vaccines Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table GlaxoSmithKline, plc (U.K.) Information
Table Multivalent Vaccines Sales, Cost, Margin of GlaxoSmithKline, plc (U.K.)
Table Pfizer, Inc. (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of Pfizer, Inc. (U.S.)
Table Merck & Co., Inc. (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of Merck & Co., Inc. (U.S.)
Table Sanofi Pasteur SA (France) Information
Table Multivalent Vaccines Sales, Cost, Margin of Sanofi Pasteur SA (France)
Table Astellas Pharma Inc. (Japan) Information
Table Multivalent Vaccines Sales, Cost, Margin of Astellas Pharma Inc. (Japan)
Table CSL Limited (Australia) Information
Table Multivalent Vaccines Sales, Cost, Margin of CSL Limited (Australia)
Table Emergent BioSolutions, Inc. (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of Emergent BioSolutions, Inc. (U.S.)
Table Johnson & Johnson (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of Johnson & Johnson (U.S.)
Table MedImmune, LLC (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of MedImmune, LLC (U.S.)
Table Serum Institute of India Pvt. Ltd. (India) Information
Table Multivalent Vaccines Sales, Cost, Margin of Serum Institute of India Pvt. Ltd. (India)
Table Bavarian Nordic (Denmark) Information
Table Multivalent Vaccines Sales, Cost, Margin of Bavarian Nordic (Denmark)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Information
Table Multivalent Vaccines Sales, Cost, Margin of Mitsubishi Tanabe Pharma Corporation (Japan)
Table Daiichi Sankyo (Japan) Information
Table Multivalent Vaccines Sales, Cost, Margin of Daiichi Sankyo (Japan)
Table Protein Sciences Corporation (U.S.) Information
Table Multivalent Vaccines Sales, Cost, Margin of Protein Sciences Corporation (U.S.)
Table Panacea Biotec (India) Information
Table Multivalent Vaccines Sales, Cost, Margin of Panacea Biotec (India)

List Of Figures

LIST OF FIGURES

Figure Global Multivalent Vaccines Market Share by Type in 2018
Figure Global Multivalent Vaccines Market Share by Application in 2018
Figure Global Multivalent Vaccines Market Share by Region in 2018
Figure North America Multivalent Vaccines Market Share by Region in 2018
Figure Global Multivalent Vaccines Market Share by Region in 2017 (Million USD)
Figure Global Multivalent Vaccines Market Share by Region in 2017 (Volume)
Figure Global Multivalent Vaccines Market Share by Company in 2017 (Million USD)
Figure Global Multivalent Vaccines Market Share by Company in 2017 (Volume)
Figure Global Multivalent Vaccines Market Share by Type in 2017 (Million USD)
Figure Global Multivalent Vaccines Market Share by Type in 2017 (Volume)
Figure Global Multivalent Vaccines Market Share by Application in 2017 (Million USD)
Figure Global Multivalent Vaccines Market Share by Application in 2017 (Volume)
Figure Global Multivalent Vaccines Market Forecast, 2018-2023 (Million USD)
Figure Global Multivalent Vaccines Market Forecast, 2018-2023 (Volume)
Figure North America Multivalent Vaccines Market Share by Region in 2017 (Million USD)
Figure North America Multivalent Vaccines Market Share by Region in 2017 (Volume)
Figure North America Multivalent Vaccines Market Share by Company in 2017 (Million USD)
Figure North America Multivalent Vaccines Market Share by Company in 2017 (Volume)
Figure North America Multivalent Vaccines Market Share by Type in 2017 (Million USD)
Figure North America Multivalent Vaccines Market Share by Type in 2017 (Volume)
Figure North America Multivalent Vaccines Market Share by Application in 2017 (Million USD)
Figure North America Multivalent Vaccines Market Share by Application in 2017 (Volume)
Figure North America Multivalent Vaccines Market Forecast, 2018-2023 (Million USD)
Figure North America Multivalent Vaccines Market Forecast, 2018-2023 (Volume)
Figure United States Multivalent Vaccines Market Share by Type in 2017 (Million USD)
Figure United States Multivalent Vaccines Market Share by Type in 2017 (Volume)
Figure United States Multivalent Vaccines Market Share by Application in 2017 (Million USD)
Figure United States Multivalent Vaccines Market Share by Application in 2017 (Volume)
Figure United States Multivalent Vaccines Market Forecast, 2018-2023 (Million USD)
Figure United States Multivalent Vaccines Market Forecast, 2018-2023 (Volume)
Figure Canada Multivalent Vaccines Market Share by Type in 2017 (Million USD)
Figure Canada Multivalent Vaccines Market Share by Type in 2017 (Volume)
Figure Canada Multivalent Vaccines Market Share by Application in 2017 (Million USD)
Figure Canada Multivalent Vaccines Market Share by Application in 2017 (Volume)
Figure Canada Multivalent Vaccines Market Forecast, 2018-2023 (Million USD)
Figure Canada Multivalent Vaccines Market Forecast, 2018-2023 (Volume)
Figure Mexico Multivalent Vaccines Market Share by Type in 2017 (Million USD)
Figure Mexico Multivalent Vaccines Market Share by Type in 2017 (Volume)
Figure Mexico Multivalent Vaccines Market Share by Application in 2017 (Million USD)
Figure Mexico Multivalent Vaccines Market Share by Application in 2017 (Volume)
Figure Mexico Multivalent Vaccines Market Forecast, 2018-2023 (Million USD)
Figure Mexico Multivalent Vaccines Market Forecast, 2018-2023 (Volume)